United States
Germany
Japan
United Kingdom
China
CD19 mouse monoclonal antibody, clone OTI3G7 (formerly 3G7)
| Applications | FC, IF, IHC, WB |
| Reactivities | Human |
Antibodies
ROMO1 mouse monoclonal antibody, clone OTI2C12 (formerly 2C12)
| Applications | IF, IHC, WB |
| Reactivities | Human, Mouse, Rat |
CNY 1,999.00
CNY 2,700.00
现货
ACE2 mouse monoclonal antibody,clone OTI2G7
| Applications | IHC, WB |
| Reactivities | Human |
CNY 1,999.00
CNY 2,700.00
现货
ACE2 mouse monoclonal antibody, clone OTI1G4 (formerly 1G4)
| Applications | IHC, WB |
| Reactivities | Human |
CNY 1,999.00
CNY 2,700.00
现货
Anti-CYP2E1 (Cytochrome P450 2E1) mouse monoclonal antibody, clone OTI5B9 (formerly 5B9)
| Applications | IF, IHC, WB |
| Reactivities | Human |
CDCP1 mouse monoclonal antibody, clone OTI2C1 (formerly 2C1)
| Applications | FC, IF, IHC, WB |
| Reactivities | Human |
CD40 mouse monoclonal antibody, clone OTI1F12 (formerly 1F12)
| Applications | IHC, WB |
| Reactivities | Human |
TMEM100 mouse monoclonal antibody, clone OTI10G3 (formerly 10G3)
| Applications | IF, IHC, WB |
| Reactivities | Human, Mouse, Rat |
TNFRSF10B mouse monoclonal antibody, clone OTI1B9 (formerly 1B9)
| Applications | IHC, WB |
| Reactivities | Human |
CD68 mouse monoclonal antibody, clone OTI3B6 (formerly 3B6)
| Applications | FC, IHC, WB |
| Reactivities | Human |
CNY 1,999.00
CNY 2,700.00
现货
MSR1 mouse monoclonal antibody, clone OTI9E5 (formerly 9E5)
| Applications | WB |
| Reactivities | Human |
Anti-CD36 mouse monoclonal antibody, clone OTI3F4 (formerly 3F4)
| Applications | FC, IF, IHC, WB |
| Reactivities | Human, Rat |
CD163 mouse monoclonal antibody, clone OTI1B4 (formerly 1B4)
| Applications | IF, IHC, WB |
| Reactivities | Human |
CNY 1,999.00
CNY 2,700.00
现货
PDGFRA mouse monoclonal antibody, clone OTI1C10 (formerly 1C10)
| Applications | WB |
| Reactivities | Human, Mouse, Rat |
ICAM1 mouse monoclonal antibody, clone OTI2H4 (formerly 2H4)
| Applications | FC, IF, IHC, WB |
| Reactivities | Human |
活动过滤器
优化搜索结果
Category
Target Symbol
- CD163 (5)
- LAT2 (5)
- PD-L1 (5)
- CD19 (4)
- CD1C (4)
- CD4 (4)
- CD56 (4)
- BCL2 (3)
- CD20 (3)
- CD36 (3)
- CD8A (3)
- ROMO1 (3)
- AFG3L2 (2)
- AMYLOID PRECURSOR PROTEIN (2)
- ANGIOTENSIN CONVERTING ENZYME 2 (2)
- AQUAPORIN 1 (2)
- BCL X (2)
- BTN3A2 (2)
- C20ORF30 (2)
- CD26 (2)
- CD31 (2)
- CD40 (2)
- CD44 (2)
- CD68 (2)
- CD7 (2)
- CLEC4E (2)
- CYTOCHROME P450 2E1 (2)
- DPP8 (2)
- EPCAM (2)
- ERP72 (2)
- FGFR3 (2)
- FNDC4 (2)
- GDAP1L1 (2)
- ICAM1 (2)
- IGF1 RECEPTOR (2)
- MACROPHAGE SCAVENGER RECEPTOR I (2)
- MAN1 (2)
- MET (2)
- MSMB (2)
- PD1 (2)
- SIL1 (2)
- SPG7 (2)
- SYNTENIN (2)
- TRKA (2)
- TRKB (2)
- TRPM4 (2)
- VMAT2 (2)
- APMAP (1)
- CD105 (1)
- CD11B (1)
- CD2 (1)
- CD22 (1)
- CD299 (1)
- CD30 (1)
- CD39 (1)
- CD5 (1)
- CD64 (1)
- CD9 (1)
- CDCP1 (1)
- CTLA4 (1)
- CYP7B1 (1)
- DR5 (1)
- E CADHERIN (1)
- EGFR (1)
- EMA (1)
- HE4 (1)
- HGF (1)
- HLA-DRB5 (1)
- HLAA (1)
- INTEGRIN BETA 1 (1)
- L1CAM (1)
- LGR5 (1)
- LMAN1 (1)
- MELANA (1)
- PCDH7 (1)
- PD L2 (1)
- PDGF RECEPTOR ALPHA (1)
- PDGF RECEPTOR BETA (1)
- PMP22 (1)
- RNF149 (1)
- ROS1 (1)
- SCARB1 (1)
- SYNTAXIN 1A (1)
- TIM 3 (1)
- TLR8 (1)
- TMEM100 (1)
- TNF ALPHA (1)
- TRPM8 (1)
- VCAM1 (1)
- VE CADHERIN (1)
- VIP (1)
Reactivities
Antibody Hosts
Knockout (KO) Validation
Assay Types
Pathways
- Cell adhesion molecules (CAMs) (36)
- Hematopoietic cell lineage (33)
- Pathways in cancer (19)
- Primary immunodeficiency (13)
- Focal adhesion (12)
- Cytokine-cytokine receptor interaction (11)
- Endocytosis (11)
- T cell receptor signaling pathway (11)
- Colorectal cancer (10)
- MAPK signaling pathway (10)
- Antigen processing and presentation (9)
- Apoptosis (9)
- Melanoma (9)
- Leukocyte transendothelial migration (8)
- Prostate cancer (8)
- Neurotrophin signaling pathway (7)
- Regulation of actin cytoskeleton (7)
- Adherens junction (6)
- Amyotrophic lateral sclerosis (ALS) (6)
- ECM-receptor interaction (6)
- Small cell lung cancer (6)
- Viral myocarditis (6)
- Allograft rejection (5)
- Autoimmune thyroid disease (5)
- B cell receptor signaling pathway (5)
- Glioma (5)
- Natural killer cell mediated cytotoxicity (5)
- Systemic lupus erythematosus (5)
- Adipocytokine signaling pathway (4)
- Asthma (4)
- Axon guidance (4)
- Bladder cancer (4)
- Prion diseases (4)
- Toll-like receptor signaling pathway (4)
- Alzheimer's disease (3)
- Calcium signaling pathway (3)
- Epithelial cell signaling in Helicobacter pylori infection (3)
- Gap junction (3)
- Graft-versus-host disease (3)
- PPAR signaling pathway (3)
- Pancreatic cancer (3)
- Renal cell carcinoma (3)
- Thyroid cancer (3)
- Type I diabetes mellitus (3)
- Arachidonic acid metabolism (2)
- Chronic myeloid leukemia (2)
- Dilated cardiomyopathy (2)
- Drug metabolism - cytochrome P450 (2)
- Endometrial cancer (2)
- Hypertrophic cardiomyopathy (HCM) (2)
- Jak-STAT signaling pathway (2)
- Linoleic acid metabolism (2)
- Long-term depression (2)
- Lysosome (2)
- Metabolic pathways (2)
- Metabolism of xenobiotics by cytochrome P450 (2)
- Oocyte meiosis (2)
- Parkinson's disease (2)
- Pathogenic Escherichia coli infection (2)
- Progesterone-mediated oocyte maturation (2)
- Renin-angiotensin system (2)
- Vibrio cholerae infection (2)
- Arrhythmogenic right ventricular cardiomyopathy (ARVC) (1)
- Dorso-ventral axis formation (1)
- ErbB signaling pathway (1)
- Fc epsilon RI signaling pathway (1)
- Fc gamma R-mediated phagocytosis (1)
- GnRH signaling pathway (1)
- NOD-like receptor signaling pathway (1)
- Non-small cell lung cancer (1)
- Primary bile acid biosynthesis (1)
- Purine metabolism (1)
- Pyrimidine metabolism (1)
- RIG-I-like receptor signaling pathway (1)
- SNARE interactions in vesicular transport (1)
- TGF-beta signaling pathway (1)
- Type II diabetes mellitus (1)
- p53 signaling pathway (1)
